Low-Dose Versus High-Dose Aspirin After Percutaneous Coronary Intervention

Anticoagulation in Neurointerventions

“…the beneficial role of ASA has been corroborated by recent studies demonstrating insufficient platelet inhibition to be correlated with adverse outcome [38,39] although not all platelet function tests in a previous study of Breet et al [40] were of predictive value. the optimal dosing of aSa may not be crucial as the results for low dose aSa (80 mg/day) and high dose (up to 325 mg/day) did not differ substantially, at least after interventions, in recent studies [41,42]. In 10-20% of the patients a cerebrovascular event will not be prevented by ASA.…”